COA upholds previous decision vs GSIS for ‘unnecessary’ antibiotics purchase
THE Commission on Audit (COA) has rebuked Government Service Insurance System (GSIS) officials for procuring “unnecessary and irregular” Oseltamivir capsules worth P25.13 million in 2006, saying that procurement of medicine is not in the GSIS’ purview.
Former GSIS chairperson Winston F. Garcia and several board members have been found liable for the irregularity.
The audit commission was reacting to a 2015 petition by several GSIS officials for review of a 2012 Notice of Disallowance.
“It must be emphasized that the fund of GSIS is a social insurance fund, which shall be used to finance the benefits administered by the GSIS. The procurement of medicines for the treatment of afflicted GSIS members is not a benefit that is being administered by GSIS,” stated the COA decision dated July 4.
The GSIS procured 476,300 capsules of the anti-viral medication, also known as Tamiflu, for the use of its members during the height of the Avian Influenza scare in the country.
According to the COA report, GSIS and United Laboratories, Inc. (UNILAB) entered into a memorandum of agreement to ensure that the former “will have ready access to the supply of Oseltamivir capsules in case of Avian Influenza outbreak in the country.”
However, the auditors reported in 2007 and in 2010 that the purchased capsules were only distributed to GSIS officers and employees on 2009, long after the Avian Flu scare in 2006, and only 109,880 or the 476,300 capsules procured were distributed.
In addition to that, the state auditors said that the GSIS cannot justify its procurement as there was no national emergency declared then.
“There was no national emergency declared by the President as to the outbreak of Avian Influenza in the country. Thus, there was no urgent necessity for the procurement of Oseltamivir capsules,” the decision read.
It added, “GSIS, being a social institution, does not have the required skills and expertise to determine the existence of Avian Influenza, and treatment of the patient afflicted with said flu can only be done in the hospital according to the World Health Organization.”
In the initial findings, then GSIS chairperson Winston F. Garcia and board members Bernardino R. Abes, Jesse H.T. Andres, Daniel C. Gutierrez, Esperanza S. Ocampo, Reynaldo P. Palmiery, Raymundo A. Lapating, and Jesus I. Santos were found liable for the unnecessary procurement.
In COA’s modified notice, Mr. Lapating and Ms. Ocampo were excluded from liability for having no participation in approving the deal.
The case will be referred to the Office of the Ombudsman for investigation and filing of appropriate charges if warranted. — Vince Angelo C. Ferreras